EU approves aortic heart valve from Sorin Group

02/3/2011 | CardiovascularBusiness.com

Sorin Group has been granted CE Mark approval for its aortic valve replacement device, the Perceval S, designed for aortic stenosis patients. Surgeons testing the device in a clinical study were able to perform isolated and complex valve replacement procedures in half the time the traditional method takes, the company said.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN